Bright Uro, Inc. — Form D/A

Bright Uro, Inc. of Irvine, CA, a company, filed a Form D amendment with the SEC on 2025-07-03. The offering totals $32.1M, of which $31.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2025-07-03
Form: D/A
Accession: 0002002648-25-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $32.1M
Amount sold: $31.0M
Remaining: $1.0M
Investors: 108
Date of first sale: 2023-11-14
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-498816

Issuer

Name: Bright Uro, Inc.
CIK: 0002002648
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 3 Goddard, Irvine, CA, 92618
Phone: (949) 590-0555

Officers, directors & promoters (9)

Name	Role	Location
Kevin Herschberger	Executive Officer	Irvine, CA
Michael Frazzette	Director	Irvine, CA
Kevin Hershberger	Executive Officer	Irvine, CA
Derek Herrera	Director	Irvine, CA
Derek Herrera	Executive Officer	Irvine, CA
Sherman Williams	Director	Irvine, CA
Kurt Azarbarzin	Director	Irvine, CA
Mike Frazzette	Director	Irvine, CA
Martha Aronson	Director	Irvine, CA

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2025-09-05	D/A	$15.0M	$15.0M
2025-07-03	D	$14.9M	$14.7M
2024-09-23	D/A	$32.1M	$29.3M
2024-05-10	D/A	$30.0M	$20.1M
2023-12-05	D	$23.0M	$13.0M

More